Senior Resident Infectious Diseases
All India Institute of Medical Sciences, New Delhi, India
Disclosure(s): No financial relationships to disclose
Dr Sehgal participated in programmes like Infectious Diseases Society of America (IDSA) fellows-mentorship. He connected with Dr Saman Nematollahi, program director of Infectious Diseases fellowship program at University of Arizona College of Medicine, Tucson USA. Dr Sehgal significantly to the Global Infectious Diseases Fellows Cup (IDFC) organised by University of Alabama, Birmingham and made board style questions for the season 2021 and 2022. Dr Sehgal participated and also presented in the weekly ID Journal Club in the department of Medicine at AIIMS, New Delhi.
Dr Sehgal has contributed significantly to the field of Infectious Diseases, authoring the national module on extra-pulmonary tuberculosis (EPTB) management adopted and published by WHO India and Central TB Division (CTD), Ministry of Health and Family Welfare (MOHFW) launched by our honourable The Prime Minister of India Shri Narender Modi ji on World TB Day 24 March 2023 at Varanasi, India.
Research and Publications
1. Section on “Tuberculosis Diagnostics” in Training Module on Extrapulmonary Tuberculosis 2023 (Central TB Division, https://tbcindia.gov.in)
2. Research paper in the international peer review journal Tropical Medicine and Infectious Diseases 2020.
3. Research paper in ANAEROBE Journal which is an international peer reviewed journal with impact factor of 2.78 Detection of Rickettsial pathogens in patients presenting with acute febrile illness at PGIMER, Chandigarh
Detection of co-infection of Gardnerella vaginalis and Atopobium vaginae using qualitative PCR: A better predictor of bacterial vaginosis
4. Research paper available in preprint on medRx Genomic analysis of symptomatic SARS-CoV-2 Vaccine breakthrough infections from a tertiary care centre in India
5. Research paper published in the journal of infection in developing countries which is an international peer reviewed journal with an impact factor of 2.1 Persistence of SARS CoV-2 in COVID-19 patients during the second wave of the pandemic in India